Position in AMGN
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$10,291,812
+$752,103 QoQ
Shares Held
28,421
+4.8% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
1.48%
of 13F equity value
Holder Rank
#542
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 12%
Shared 0%
None 88%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TOTH FINANCIAL ADVISORY CORP holds $48,675,880 across 11 Drug Manufacturers - General names. AMGN ranks #3 (21.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
63,494 | $16,125,571 | |
| 2 | ABBV |
AbbVie Inc.
|
59,705 | $15,024,166 | |
| 3 | AMGN |
Amgen Inc
This page
|
28,421 | $10,291,812 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
97,037 | $5,591,271 | |
| 5 | LLY |
ELI LILLY & Co
|
1,207 | $1,447,712 | |
| 6 | PFE |
Pfizer Inc
|
4,200 | $101,136 | |
| 7 | MRK |
Merck & Co., Inc.
|
539 | $69,261 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
117 | $14,781 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,291,812 | 28,421 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $9,539,709 | 27,113 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $8,738,195 | 26,697 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $7,249,153 | 25,688 | Shares | Sole | 2025-10-09 | |
| 2025-06-30 | $7,172,067 | 25,687 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $7,844,829 | 25,180 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $6,662,479 | 25,562 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $8,415,802 | 26,119 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $8,449,272 | 27,042 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $7,893,860 | 27,764 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $8,089,329 | 28,086 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $7,389,287 | 27,494 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $6,157,280 | 27,733 | Shares | Sole | 2023-07-24 | |
| 2023-03-31 | $6,880,688 | 28,462 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $7,555,102 | 28,766 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $6,299,479 | 27,948 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $6,567,640 | 26,994 | Shares | Sole | 2022-07-25 | |
| 2022-03-31 | $5,786,027 | 23,927 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $4,986,909 | 22,167 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $5,693,491 | 26,774 | Shares | Sole | 2021-10-20 | |
| 2021-06-30 | $6,769,181 | 27,771 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $6,798,733 | 27,325 | Shares | Sole | 2021-04-20 | |
| 2020-12-31 | $6,203,471 | 26,981 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $6,941,109 | 27,310 | Shares | Sole | 2020-10-16 | |
| 2020-06-30 | $6,118,444 | 25,941 | Shares | Sole | 2020-07-14 | |
| 2020-03-31 | $4,452,153 | 21,961 | Shares | Sole | 2020-04-20 | |
| No filing history on record for this holder in this stock. | ||||||